bpv Huegel advises on acquisition of Hofer Medical

6 March 2019. bpv Huegel advised under the leadership of Corporate M&A Partner Elke Napokoj Allistro Capital Fonds, Germany, on the acquisition of the medical device manufacturer Hofer Medical. bpv Huegel was entrusted with the preparation of the transaction documents as well as the structuring of the acquisition including a reorganisation of the corporate governance.

Hofer Medical has been developing osteosynthesis systems for traumatology and orthopaedics at the Fürstenfeld site since 1976 and distributes them in particular via subsidiaries in Italy, Germany and Poland.

Allistro Capital Fonds invests in companies whose tradition must be preserved and acts as an active shareholder who contributes to the successful future development of the company. The focus of Allistro Capital is, among other things, on the area of medical technology. The fund already holds an investment in Graz.

“It was an exciting project for the entire bpv Huegel team and we are delighted to have been involved in the transaction. The project underlines the strength of bpv Huegel for cross-border transactions and the combination of know-how in M&A law, regulatory and IP,” said Elke Napokoj.

The bpv Huegel team, led by Elke Napokoj (Corporate Law/M&A), consisted of Michaela Pelinka (Corporate Law/M&A), Christian F. Schneider (Regulatory), Walter Niedermüller (Employment Law), Sonja Dürager (IP) and Gerhard Fussenegger (Competition Law).

The sellers were advised by Viehböck Breiter Nau.

Press release